Only 1% to 2% of lung cancers are carcinoid tumors. How are these rare tumors different from the more common types of lung cancers? Here’s what you need to know.

Immunohistochemical analysis of tumor-infiltrating dendritic cells (DC) in small-cell lung carcinoma (SCLC) and carcinoid tumor (CT) tissues. Tissue slides (6 μm) from optimal cutting temperature ...

Non-small-cell lung cancers (n=26), small-cell lung cancers (n=10), bronchopulmonary carcinoid tumors (n=29), and non-neoplastic lung (n=46) were investigated for secretin receptor protein ...

NSCLC is the most common lung cancer, accounting for about 85% of all cases. NSCLC has three main types designated by the type of cells found in the tumor. They are: ...

Background: Carcinoid tumor of the lung is a rare neuroendocrine tumor (NET), little is known of the in-hospital characteristics of this tumor. This study aims to describe the characteristics of ...

Carcinoid lung tumour is a rare type of lung tumour, which develops from a special type of cell present in the lungs called neuroendocrine cells. Written by : Dr Poonam Sachdev Updated at: Jun 28 ...

Small cell lung cancer is a type of neuroendocrine tumor (NET). Learn more about the different NETs, including how risk factors, diagnosis, and treatment differ.

Small-cell lung cancer (SCLC) is the most common type of lung neuroendocrine tumor (NET). We review what that means and discuss other types of NETs.

Lung carcinoid tumor does not cause carcinoid syndrome, which is generally the case with GI tumor. The symptoms of the lung carcinoid tumor are: Cough, with or without bloody sputum or phlegm; ...

As compared with other types of lung cancers, prognosis of carcinoid lung tumours is better. Overall 5-year survival rate of people with carcinoid lung tumours is about 78%-95% and 10-year ...

According to the American Cancer Society, 89% of people with carcinoid tumors in the lung survive their cancer for over 5 years. And 94% of people with carcinoid tumors in the gastrointestinal ...

Tumor markers for small cell lung cancer (SCLC) are measurable using blood tests, such as neuron-specific enolase (NSE). They can support the identification and management of cancer. Doctors use a ...